{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:45:37Z","timestamp":1789191937062,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clp.2025.06.007","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T19:22:31Z","timestamp":1752693751000},"page":"461-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Newborn Screening for Hemoglobin Disorders"],"prefix":"10.1016","volume":"52","author":[{"given":"Bradford L.","family":"Therrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2025.06.007_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","article-title":"History and current status of newborn screening for hemoglobinopathies","volume":"34","author":"Benson","year":"2010","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.clp.2025.06.007_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0925-6164(92)90025-Z","article-title":"The origin of newborn screening","volume":"1","author":"Guthrie","year":"1992","journal-title":"Screening"},{"key":"10.1016\/j.clp.2025.06.007_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/bjh.15600","article-title":"Newborn screening for sickle cell disease in Europe: recommendations from a pan-European consensus conference","volume":"183","author":"Lobitz","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clp.2025.06.007_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.puhe.2007.12.005","article-title":"Neonatal screening and clinical care programmes for sickle cell disorders in Sub-Saharan Africa: lessons from pilot studies","volume":"122","author":"Tshilolo","year":"2008","journal-title":"Public Health"},{"key":"10.1016\/j.clp.2025.06.007_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/ijns5010005","article-title":"Newborn screening for sickle cell disease in the Caribbean: an update of the present situation and of the disease prevalence","volume":"5","author":"Knight-Madden","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/asheducation-2009.1.19","article-title":"Newborn screening for non-sickling hemoglobinopathies","author":"Hoppe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clp.2025.06.007_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jpeds.2010.10.042","article-title":"Weighing the evidence for newborn screening for hemoglobin H disease","volume":"158","author":"Kemper","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2025.06.007_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.15585\/mmwr.mm6936a7","article-title":"Newborn screening practices and alpha-thalassemia detection \u2013 united States, 2016","volume":"69","author":"Bender","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2025.06.007_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/ijns7020030","article-title":"Successful implementation of newborn screening for hemoglobin disorders in the Philippines","volume":"7","author":"Padilla","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ijns11010002","article-title":"Consolidated newborn bloodspot screening efforts in developing countries in the Asia Pacific\u20142024","volume":"11","author":"Therrell","year":"2025","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12288-014-0432-y","article-title":"Implementation of newborn screening for hemoglobin H disease in mainland China","volume":"31","author":"Xie","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clp.2025.06.007_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/gim.2015.143","article-title":"Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from hardy-weinberg equilibrium","volume":"18","author":"Piel","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.clp.2025.06.007_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ijns10020038","article-title":"Current status of newborn bloodspot screening worldwide 2024: a comprehensive review of recent activities (2020-2023)","volume":"10","author":"Therrell","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/109065701753145538","article-title":"Universal newborn screening for Hb H disease in California","volume":"5","author":"Lorey","year":"2001","journal-title":"Genet Test"},{"key":"10.1016\/j.clp.2025.06.007_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1258\/jms.2012.012070","article-title":"Reply: relationship between neonatal screening results by high-performance liquid chromatography and the number of alpha-thalassaemia gene mutations: consequences for the cut-off","volume":"19","author":"Goodness","year":"2012","journal-title":"J Med Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/ah\/3854629","article-title":"Variability in notification of positive newborn screening results for sickle cell trait across the United States","volume":"2024","author":"Scott","year":"2024","journal-title":"Adv Hematol"},{"key":"10.1016\/j.clp.2025.06.007_bib18","first-page":"1967","article-title":"Characterization of health and safety resources for athletes with sickle cell trait at NCAA institutions","volume":"38","author":"Yeargin","year":"2024","journal-title":"J Strength Cond Res"},{"key":"10.1016\/j.clp.2025.06.007_bib19","series-title":"CLSI guideline NBS08","article-title":"Newborn screening for hemoglobinopathies","author":"Therrell","year":"2019"},{"key":"10.1016\/j.clp.2025.06.007_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283024","article-title":"A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry","volume":"18","author":"Tesorero","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2025.06.007_bib23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1515\/cclm-2023-1250","article-title":"MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC","volume":"62","author":"El","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clp.2025.06.007_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ijns10040077","article-title":"Evaluation of a new tandem mass spectrometry method for sickle cell disease newborn screening","volume":"10","author":"Renoux","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcmd.2017.08.010","article-title":"The pressing need for point-of-care diagnostics for sickle cell disease: a review of current and future technologies","volume":"67","author":"McGann","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clp.2025.06.007_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2019.10.025","article-title":"Emerging point-of-care technologies for sickle cell disease diagnostics","volume":"501","author":"Ilyas","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clp.2025.06.007_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089056","article-title":"Acceptability, barriers and facilitators of using dried blood spots-point-of-care testing for sickle cell disease in Africa: an implementation science protocol for a multinational qualitative study","volume":"14","author":"Nnodu","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.clp.2025.06.007_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309045","article-title":"Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases","volume":"19","author":"Purohit","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2025.06.007_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcp\/aqz108","article-title":"Multicenter evaluation of HemoTypeSC as a point-of-care sickle cell disease rapid diagnostic test for newborns and adults across India","volume":"153","author":"Mukherjee","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clp.2025.06.007_bib28","article-title":"Evaluation of microchip-based point-of-care device \u201cgazelle\u201d for diagnosis of sickle cell disease in India","volume":"8","author":"Shrivas","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clp.2025.06.007_bib29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-4105","article-title":"Newborn screening for sickle cell disease using point-of-care testing in low-income setting","volume":"144","author":"Alvarez","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2025.06.007_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12687-020-00463-7","article-title":"Empowering newborn screening programs in African countries through establishment of an international collaborative effort","volume":"11","author":"Therrell","year":"2020","journal-title":"J Community Genet"},{"key":"10.1016\/j.clp.2025.06.007_bib31","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2352-3026(20)30006-5","article-title":"SickleInAfrica","volume":"7","author":"Makani","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clp.2025.06.007_bib32","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1182\/bloodadvances.2022007698","article-title":"The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology","volume":"6","author":"Green","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.clp.2025.06.007_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057623","article-title":"Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries","volume":"12","author":"Archer","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.clp.2025.06.007_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.seminhematol.2023.06.001","article-title":"Access to essential therapy for sickle cell disease in Africa: experience from a national program in Ghana","volume":"60","author":"Nyonator","year":"2023","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clp.2025.06.007_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMp2201763","article-title":"Bringing sickle-cell treatments to children in Sub-Saharan Africa","volume":"387","author":"Zhou","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2025.06.007_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/phar.2792","article-title":"Hydroxyurea for children with sickle cell disease in Sub-Saharan Africa: a summary of the evidence, opportunities, and challenges","volume":"43","author":"Dexter","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clp.2025.06.007_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.seminhematol.2023.08.002","article-title":"Current challenges and new approaches to implementing optimal management of sickle cell disease in Sub-Saharan Africa","volume":"60","author":"Ally","year":"2023","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clp.2025.06.007_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41434-023-00429-7","article-title":"Looking ahead: ethical and social challenges of somatic gene therapy for sickle cell disease in Africa","volume":"31","author":"Munung","year":"2024","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.clp.2025.06.007_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ahg.12558","article-title":"The dawn of a cure for sickle cell disease through CRISPR-Based treatment: a critical test of equity in public health genomics","volume":"89","author":"Mboowa","year":"2024","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.clp.2025.06.007_bib41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1186\/s12889-024-17761-1","article-title":"Sickle cell trait in S\u00e3o Tom\u00e9 e Pr\u00edncipe: a population-based prevalence study in women of reproductive age","volume":"24","author":"Queiroz","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clp.2025.06.007_bib42","article-title":"Sickle cell anemia screening in newborns and analysis of haplotypes in patients from Santiago Island","volume":"2024","author":"Freire","year":"2024","journal-title":"Cape Verde Anemia"},{"key":"10.1016\/j.clp.2025.06.007_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.25259\/JHAS_11_2023","article-title":"Newborn screening for sickle cell disease in Lubumbashi, democratic Republic of the Congo: an update on the prevalence of the disease","volume":"3","author":"Katamea","year":"2023","journal-title":"J Hematol Allied Sci"},{"key":"10.1016\/j.clp.2025.06.007_bib44","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2352-3026(23)00096-0","article-title":"Defining global strategies to improve outcomes in sickle cell disease: a lancet haematology commission","volume":"10","author":"Piel","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clp.2025.06.007_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2024000678","article-title":"Sickle cell disease in India: the journey and hope for the future","volume":"2024","author":"Gupta","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clp.2025.06.007_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70033","article-title":"Casting light on the national mission to eliminate sickle cell disease in India","volume":"8","author":"Piel","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.clp.2025.06.007_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns4040031","article-title":"Newborn screening for sickle cell disease: indian experience","volume":"4","author":"Colah","year":"2018","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"10.1016\/j.clp.2025.06.007_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12098-024-05392-8","article-title":"Unveiling the burden of sickle cell anemia: a pilot study validating dried blood spots for newborn screening","volume":"92","author":"Karra","year":"2025","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.clp.2025.06.007_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijns10010021","article-title":"Iowa newborn screening program experience with hemoglobinopathy screening over the last two decades and its increasing global relevance","volume":"10","author":"Jilek","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib50","doi-asserted-by":"crossref","DOI":"10.2196\/64995","article-title":"The prevalence of sickle cell disease in Colorado and methodologies of the Colorado sickle cell data collection program: public health surveillance study","volume":"10","author":"Miller","year":"2024","journal-title":"JMIR Public Health Surveill"},{"issue":"suppl 1","key":"10.1016\/j.clp.2025.06.007_bib51","article-title":"Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023","volume":"2","author":"Hays","year":"2024","journal-title":"Gen Med Open"},{"key":"10.1016\/j.clp.2025.06.007_bib52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.15585\/mmwr.mm7312a1","article-title":"Birth prevalence of sickle cell disease and county-level social vulnerability - sickle cell data collection program, 11 states, 2016-2020","volume":"73","author":"Kayle","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2025.06.007_bib53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.semperi.2015.03.008","article-title":"Newborn screening for sickle cell diseases in the United States: a review of data spanning 2 decades","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.clp.2025.06.007_bib54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jha2.926","article-title":"Positive impacts of universal newborn screening on the outcome of children with sickle cell disease in the province of Quebec: a retrospective cohort study","volume":"5","author":"Kazadi","year":"2024","journal-title":"EJHaem"},{"key":"10.1016\/j.clp.2025.06.007_bib55","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00277-024-05788-8","article-title":"Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)","volume":"103","author":"Marco S\u00e1nchez","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clp.2025.06.007_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/ijns9040055","article-title":"A newborn screening program for sickle cell disease in Murcia (Spain)","volume":"9","author":"S\u00e1nchez-Villalobos","year":"2023","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/ijns10040069","article-title":"Newborn screening for sickle cell disease in Catalonia between 2015 and 2022 - epidemiology and impact on clinical events","volume":"10","author":"Gonz\u00e1lez de Aledo-Castillo","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib58","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1055\/s-0042-1759646","article-title":"Neonatal screening for sickle cell disease in Western Andalusia: results and lessons learnt after 3 years of implementation","volume":"41","author":"N\u00fa\u00f1ez-Jurado","year":"2024","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.clp.2025.06.007_bib59","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00277-023-05539-1","article-title":"Madrid newborn sickle cell disease cohort: clinical outcomes, stroke prevention and survival","volume":"103","author":"Garc\u00eda-Morin","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clp.2025.06.007_bib60","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/genes15111467","article-title":"A modular genetic approach to newborn screening from spinal muscular atrophy to sickle cell disease-results from six years of genetic newborn screening","volume":"15","author":"Bzdok","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.clp.2025.06.007_bib61","first-page":"529","article-title":"Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia giulia: first regional experience in Italy","volume":"22","author":"Testa","year":"2024","journal-title":"Blood Transfus"},{"key":"10.1016\/j.clp.2025.06.007_bib62","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1515\/cclm-2024-0478","article-title":"Screening for sickle cell disease: focus on newborn investigations","volume":"62","author":"Mosca","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clp.2025.06.007_bib63","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ajh.27351","article-title":"Long-term follow-up of children with sickle cell disease diagnosed by newborn screening in the Netherlands: overview of morbidity and mortality","volume":"99","author":"Vuong","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clp.2025.06.007_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijns11010010","article-title":"Newborn screening for sickle cell disease: results from a pilot study in the Portuguese population","volume":"11","author":"Rodrigues","year":"2025","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119749","article-title":"Comprehensive analysis of thalassemia alleles (CATSA) based on third-generation sequencing is a comprehensive and accurate approach for neonatal thalassemia screening","volume":"560","author":"Long","year":"2024","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clp.2025.06.007_bib67","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4236\/abb.2024.1512043","article-title":"Analysis of hemoglobin electrophoresis results and their clinical significance in neonates from Beiliu City","volume":"15","author":"Li","year":"2024","journal-title":"Adv Biosci Biotechnol"},{"key":"10.1016\/j.clp.2025.06.007_bib68","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/clinchem\/20.6.666","article-title":"Screening cord bloods for detection of sickle cell disease in Jamaica","volume":"20","author":"Serjeant","year":"1974","journal-title":"Clin Chem"},{"key":"10.1016\/j.clp.2025.06.007_bib69","doi-asserted-by":"crossref","DOI":"10.1590\/1413-81232024293.06772023en","article-title":"\u00c0g\u00f4 Sankofa: an overview of the progression of sickle cell disease in Brazil in the past two decades","volume":"29","author":"Mota","year":"2024","journal-title":"Cien Saude Colet"},{"key":"10.1016\/j.clp.2025.06.007_bib70","article-title":"Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019","volume":"42","author":"Costa","year":"2023","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.clp.2025.06.007_bib71","article-title":"Preliminary incidence of structural hemoglobinopathies in Guatemala","author":"Alban\u00e9s","year":"2022","journal-title":"J Inborn Errors Metab Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7705\/biomedica.6911","article-title":"Newborn screening in Colombia: the experience of a private program in Bogot\u00e1","volume":"44","author":"Bernal","year":"2024","journal-title":"Biomedica"},{"key":"10.1016\/j.clp.2025.06.007_bib73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/ijns10030046","article-title":"Evaluation of the newborn screening pilot for sickle cell disease in Suriname using the non-adoption, abandonment, scale-up, spread, and sustainability (NASSS) framework","volume":"10","author":"Tang","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib74","article-title":"Sickle cell disease in French Guiana: assessing 30 years of neonatal screening (1992-2021)]","volume":"4","author":"Elenga","year":"2024","journal-title":"Med Trop Sante Int"},{"key":"10.1016\/j.clp.2025.06.007_bib75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/bloodadvances.2023010104","article-title":"Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti","volume":"8","author":"Alvarez","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.clp.2025.06.007_bib76","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1097\/MPH.0000000000002864","article-title":"Newborn screening of hemoglobinopathies in a center Tunisian population","volume":"46","author":"Chaouch","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clp.2025.06.007_bib77","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/ijns10040080","article-title":"Newborn screening for six primary conditions in a clinical setting in Morocco","volume":"10","author":"El","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib78","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2024-204696","article-title":"Newborn screening program (NBS) for early detection of sickle cell disease and G6PD: the Saudi experience","volume":"144","author":"Ezzat","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.clp.2025.06.007_bib79","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12913-016-1572-6","article-title":"Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in Sub-Saharan Africa: a cost-effectiveness analysis","volume":"16","author":"Kuznik","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.clp.2025.06.007_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003668","article-title":"Sickle cell disease in Cameroon: taking out the \u201cneglect\u201d and highlighting key opportunities for sustainable control","volume":"4","author":"Saidu","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.clp.2025.06.007_bib81","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S2352-3026(20)30143-5","article-title":"Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study","volume":"7","author":"Nnodu","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clp.2025.06.007_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/ijns10040067","article-title":"A novel newborn screening program for sickle cell disease in Nigeria","volume":"10","author":"Galadanci","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.clp.2025.06.007_bib83","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12884-024-06498-9","article-title":"Health education to promote knowledge about sickle cell disease and newborn screening in pregnant women: a community-based pilot study using the healthy beginning initiative","volume":"24","author":"Ezenwosu","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.clp.2025.06.007_bib84","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1016\/S2214-109X(24)00335-8","article-title":"The 77th World Health Assembly resolution calling for newborn screening, diagnosis, and management of birth defects: moving towards action in low-income and middle-income countries","volume":"12","author":"Iroh Tam","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.clp.2025.06.007_bib85","unstructured":"World health assembly, 77. WHA77.5. accelerating progress towards reducing maternal, newborn and child mortality in order to achieve sustainable development goal targets 3.1 and 3.2. 1 June 2024, Available at: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA77\/A77_R5-en.pdf (Accessed 22 January 2025)."}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T20:27:38Z","timestamp":1755894458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510825000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0095510825000399"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2025.06.007","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newborn Screening for Hemoglobin Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2025.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}